Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
eli lilly
life sciences
national blog main
national top stories
san francisco blog main
3
×
san francisco top stories
avapritinib
blueprint medicines
boston
clinical trials
fda
genentech
indiana blog main
indiana top stories
medullary thyroid cancer
non-small cell lung cancer
novartis
pralsetinib
roche
selpercatinib
thyroid cancer
alder biopharmaceuticals
amgen
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cancer
cancer drugs
capmatinib
chronic migraine
cstone pharmaceuticals
david rind
deals
detroit blog main
detroit top stories
episodic migraine
eptinezumab
What
approval
3
×
drug
fda
medicines
3
×
blueprint
cancer
ret
address
amgen
approves
candidate
candidates
carries
certain
class
currently
designed
developed
genetic
gets
head
latest
marketing
migraine
muscle
new
nod
pact
pain
pass
preventive
regulatory
review
roche
signature
signatures
starts
targeted
targeting
team
Language
unset
Current search:
approval
×
medicines
×
" san francisco blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines